Endpoints News 生物医药· ENDPOINTS·· 3 天前AI 评分22
Novo 重塑其直接面向消费者平台;罗氏药物Gazyva再次获批
Novo revamps its direct-to-consumer platform; Roche drug Gazyva approved again
AI 导读
罗氏药物Gazyva再次获批;Novo重新推出了其直接面向消费者的NovoCare平台。
正文
Plus news about Uniquity Bio, Commit Biologics, Rosemont Pharmaceuticals, Aytu and Aclaris Therapeutics.
Novo relaunches NovoCare direct-to-consumer platform: Novo is revamping its
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news